Delcath Systems Q3 2026: Earnings Beat, Revenue Tops Forecasts, Stock Gains Momentum
Delcath Systems tops Q3 forecasts, boosting revenue to $35.1M and EPS to $0.17, driving investor confidence amid expanding liver‑cancer therapy trials.
2 minutes to read
